Clinical Trials Directory

Trials / Completed

CompletedNCT00437593

UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane Blue

UHR-OCT and HD-OCT for Preretinal Membranes: Is There a Difference Between ICG and Membrane Blue? A Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

Using the UHR-OCT and HD-OCT to evaluate early postoperative changes in patients with diagnosis preretinal membrane after successfully performed pars-plana vitrectomy and membrane peeling with two different types of dyes.

Detailed description

Surgical procedures performed are pars-plana vitrectomy and membrane peeling with or without cataract extraction and IOL implantation. The type of the dyes is randomized. The study is designed to include a total of tweny cases (10 cases with ICG and 10 cases with Membrane blue) Main outcome measures are: UHR-OCT, HD-OCT distance and near visual acuity and contrast sensitivity amsler grid secondary outcome measures are: OCT Stratus 3000 and visual field. Clinical examinations: preoperative, and follow-up examinations after 1 week, 1 months, 3 months, 6 months and 12 months.

Conditions

Interventions

TypeNameDescription
PROCEDUREppVE, MP, ICGsurgery with ILM staining
PROCEDUREppVE, MP, MBSurgery with ERM staining

Timeline

Start date
2005-09-01
Primary completion
2008-05-01
Completion
2008-05-01
First posted
2007-02-21
Last updated
2008-09-23

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00437593. Inclusion in this directory is not an endorsement.

UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane Blue (NCT00437593) · Clinical Trials Directory